pet-ct

Documents about pet-ct

• A New Clinical Pathway for Personalized Management of Borderline Resectable and Locally Advanced Pancreatic Cancer#901203ClinicalTrials.gov
• PET/CT Changes During Chemoimmunotherapy and Radiation Therapy in Patients With Stage IV Non-small Cell Lung Cancer#253003ClinicalTrials.gov
• Monitoring tumour response during chemo-radiotherapy: a parametric method using FDG-PET/CT images in patients with oesophageal cancer.#312085HAL (France)
• Comparison of the Short-Term Effect of Dietary Carbohydrate Restriction Versus Exogenous Ketone Supplementation on Myocardial Glucose Suppression and Timing to Achieve a State of Ketosis Using FDG PET/CT Serial Imaging#825730ClinicalTrials.gov
• Glucose Metabolism in Brown Adipose Tissue (BAT) in Young Healthy Men Evaluated by Deuterium Metabolic Imaging (DMI)#880106ClinicalTrials.gov
• A Head-to-head Comparison of [68Ga]Ga-FAPI and [68Ga]Ga-TATE PET/CT in Patients With Nasopharyngeal Carcinoma: a Single-center, Prospective Study#903471ClinicalTrials.gov
• PET-CT Imaging Using FDG-labeled Human Erythrocytes in Breast Cancer Patient#992714ClinicalTrials.gov
• Validation of SUV thresholds in [¹⁸F]SiTATE PET/CT for accurate meningioma segmentation#428138Open Access LMU
• Radiometabolic Therapy (RMT) With 177Lu PSMA 617 in Advanced Castration Resistant Prostate Cancer (CRPC)#845327ClinicalTrials.gov
• Development and Validation of a Deep Learning Model to Predict Distant Metastases in Nasopharyngeal Carcinoma Using Whole Slide Imaging and MRI#866577ClinicalTrials.gov
• PET/CT Imaging of Small Cell Lung Cancer Using 89Zr-DFO-SC16.56#877543ClinicalTrials.gov
• The Role of 68-Gallium-DOTATATE-PET/CT in the Imaging of Metastatic Thyroid Cancer#1009552ClinicalTrials.gov
• Combined FDG PET/CT Imaging in Response Evaluation After Radiochemotherapy in Patients With Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)#1033665ClinicalTrials.gov
• Lung Perfusion PET / CT Using Ga68-MAA for Preservation of Lung Function During Stereotactic Pulmonary Radiation Therapy#806185ClinicalTrials.gov
• Response-adapted Luvometinib With or Without Cytarabine in Langerhans Cell Histiocytosis#893877ClinicalTrials.gov
• Robotic-arm Assisted Ga-68 PSMA PET/CT Guided Transgluteal Prostate Biopsy#969894ClinicalTrials.gov
• Theranostics of Radiolabeled Somatostatin Antagonists 68Ga-DOTA-JR11 and 177Lu-DOTA-JR11 in Patients With Neuroendocrine Tumors#1030621ClinicalTrials.gov
• [68Ga]Ga-FAPI-46 in Staging of Head and Neck Carcinomas#1032495ClinicalTrials.gov
• Evaluation of Data Obtained From Three Common Imaging Techniques: Positron Emission Tomography (PET-CT), Breast Ultrasound, and Magnetic Resonance Imaging (MRI) After Neoadjuvant Chemotherapy in Patients With Breast Cancer#864272ClinicalTrials.gov
• Fluciclovine and PSMA PET/CT for the Classification and Improved Staging of Invasive Lobular Breast Cancer#897981ClinicalTrials.gov
• Stereotactic Body Radiation Therapy and FES PET/CT Imaging for the Treatment of Oligoprogressive Estrogen Receptor Positive Metastatic Breast Cancer#1045672ClinicalTrials.gov
• Prospective Cohort Study Evaluating 18FDG PET-CT for the Early Prediction of the Efficacy of Immunotherapy Associated or Not With Chemotherapy in Patients With Locally Advanced or Metastatic Non-Small Cell Broncho-Pulmonary Carcinoma#249596ClinicalTrials.gov
• Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma#858568ClinicalTrials.gov
• Pilot Study to Assess Lung Shunting of Yttrium-90 Microspheres Using PET/CT#907668ClinicalTrials.gov
• Impact of 18F-FDG PET-CT Versus Conventional Staging in the Management of Patients Presenting With Clinical Stage III Breast Cancer#843180ClinicalTrials.gov
• Methionine PET/CT Studies In Patients With Cancer#912775ClinicalTrials.gov
• Role of F-18 FDG PET-CT in neuropsychiatric systemic lupus erythematosus#450683SUNScholar
• Prospective Multicenter Study on the Predictive Role of Node-RADS Score in Patients With Prostate Cancer Who Are Candidates for Radical Prostatectomy: Comparative Analysis with Validated Nomograms and PET/CT Scan#478773IRIS
• (89Zr Panitumumab) With PET/CT for Diagnosing Metastases in Patients With Head and Neck Squamous Cell Carcinoma#800227ClinicalTrials.gov
• Transcranial Direct Current Stimulation for Long COVID Brain Fog and Fatigue#871591ClinicalTrials.gov
• Fluciclovine F18 PET/CT in Identifying the Origin of Head and Neck Squamous Cell Carcinoma in Patients With Metastatic Cervical Nodal Disease#895277ClinicalTrials.gov
• PET/CT and Lymph Node Mapping in Finding Lymph Node Metastasis in Patients With High-Risk Endometrial Cancer#969090ClinicalTrials.gov
• Evaluate The Utility Of 124I-cG250 for The Early Detection Of Response to Therapy In Patients With Metastatic Renal Cell Carcinoma#1045631ClinicalTrials.gov
• C-11 Choline PET-CT Scan in Finding Metastases in Patients With Newly Diagnosed High-Risk Prostate Cancer#830373ClinicalTrials.gov
• Positron Lymphography Via Intracervical 18F-FDG Injection for Pre-surgical Lymphatic Mapping in Stage IB1 Cervical Cancer and High-grade Endometrial Cancer#839700ClinicalTrials.gov
• 18F-T2 PET/CT Imaging for CAIX Positive Solid Tumors#881267ClinicalTrials.gov
• Cost-effectiveness of ferumoxtran-enhanced macrophage-specific-MRI and PSMA-PET/CT versus ePLND for nodal staging in primary prostate cancer: a decision analysis based on updated phase-3 trial data#374092Figshare
• PET/CT Imaging Study of the Safety and Diagnostic Performance of [68Ga]RM2 in Patients With Primary Prostate Cancer#908254ClinicalTrials.gov
• Study of 18F-Fluorodeoxyglucose (FluGlucoScan) in Patients Receiving a Treatment Planning Study of 3 Dimensional Conformal Radiation Therapy Guided by Breath Held CT and PET Imaging for Patients With Non-Small Cell Lung Cancer#828984ClinicalTrials.gov
• Randomized Trial of PSMA PET Scan Before Definitive Radiation Therapy for Prostate Cancer#891491ClinicalTrials.gov
• Whole Body Fluorine F 18 Sodium Fluoride PET/CT Scan and Whole Body MRI in Finding Bone Metastases in Patients With Prostate Cancer#806747ClinicalTrials.gov
• An Exploratory Clinical Study of Accurate Efficacy Assessment of Neoadjuvant Immunotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma Based on 68Ga-FAPI ([68Ga] Fibroblast Activation Protein Inhibitor)/¹⁸F-FDG (2-Deoxy-2-[¹⁸F]Fluoro-D-glucose) Dual Imaging#851159ClinicalTrials.gov
• 18F-Fluciclovine PET/CT Impact on Predicting Clinical Outcome of 177Lu-PSMA-617 Therapy in Patients With Prostate Cancer#873966ClinicalTrials.gov
• 68GA-PSMA-11 PET/CT Scan in Impacting Treatment Strategies for Patients With Prostate Cancer#849890ClinicalTrials.gov
• 18F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis Therapy#902921ClinicalTrials.gov
• xSPECT-based Myocardial Perfusion Scintigraphy: Consistency of Functional Values and Feasibility of Myocardial Uptake Quantitation in Patients With Suspected Coronary Artery Disease#908061ClinicalTrials.gov
• Precisión diagnóstica de resonancia magnética con contraste y tomografía por emisión de positrones-tomografía computarizada (PET/CT) con galio-68 DOTATATE en tumores neuroendocrinos: una revisión de alcance#277449Repositorio Universidad Peruana Cayetano Heredia
• Defining PET / CT Protocols With Optimized F18-FDG (Fluorodeoxyglucose) Dose, Focusing on Reduced Radiation Dose and Improved Image Quality#864044ClinicalTrials.gov
• PET-CT in Determining the Radioembolization Dose Delivered to Patients With Liver Metastasis, Primary Liver Cancer, or Biliary Cancer#968987ClinicalTrials.gov
• Fludeoxyglucose F 18-PET/CT Imaging in Assessing Response to Chemotherapy in Patients With Newly Diagnosed Stage II, Stage III, or Stage IV Hodgkin Lymphoma#863645ClinicalTrials.gov